1. |
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol, 2020, 77(4): 450-500.
|
2. |
Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol, 2017, 70(2): 252-289.
|
3. |
Baumgartner H, Hung J, Bermejo J, et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr, 2017, 30(4): 372-392.
|
4. |
Gardezi SKM, Myerson SG, Chambers J, et al. Cardiac auscultation poorly predicts the presence of valvular heart disease in asymptomatic primary care patients. Heart, 2018, 104(22): 1832-1835.
|
5. |
Lin SS, Roger VL, Pascoe R, et al. Dobutamine stress Doppler hemodynamics in patients with aortic stenosis: feasibility, safety, and surgical correlations. Am Heart J, 1998, 136(6): 1010-1016.
|
6. |
Monin JL, Monchi M, Gest V, et al. Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography. J Am Coll Cardiol, 2001, 37(8): 2101-2107.
|
7. |
Oh JK, Taliercio CP, Holmes DJ, et al. Prediction of the severity of aortic stenosis by Doppler aortic valve area determination: prospective Doppler-catheterization correlation in 100 patients. J Am Coll Cardiol, 1988, 11(6): 1227-1234.
|
8. |
Jander N, Hochholzer W, Kaufmann BA, et al. Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF. Heart, 2014, 100(24): 1946-1953.
|
9. |
Pawade T, Clavel MA, Tribouilloy C, et al. Computed tomography aortic valve calcium scoring in patients with aortic stenosis. Circ Cardiovasc Imaging, 2018, 11(3): e007146.
|
10. |
Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med, 2000, 343(9): 611-617.
|
11. |
Nazarzadeh M, Pinho-Gomes AC, Smith BK, et al. Systolic blood pressure and risk of valvular heart disease: a mendelian randomization study. JAMA Cardiol, 2019, 4(8): 788-795.
|
12. |
Rahimi K, Mohseni H, Kiran A, et al. Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults. Eur Heart J, 2018, 39(39): 3596-3603.
|
13. |
Nielsen OW, Sajadieh A, Sabbah M, et al. Assessing optimal blood pressure in patients with asymptomatic aortic valve stenosis: the Simvastatin Ezetimibe in Aortic Stenosis study (SEAS). Circulation, 2016, 134(7): 455-468.
|
14. |
Rossebo AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med, 2008, 359(13): 1343-1356.
|
15. |
Patel PA, Bavaria JE, Ghadimi K, et al. Aortic regurgitation in acute type-A aortic dissection: a clinical classifification for the perioperative echocardiographer in the era of the functional aortic annulus. J Cardiothorac Vasc Anesth, 2018, 32(8): 586-597.
|
16. |
Hamirani YS, Dietl CA, Voyles W, et al. Acute aortic regurgitation. Circulation, 2012, 126(9): 1121-1126.
|
17. |
Trost JC, Hillis LD. Intra-aortic balloon counterpulsation. Am J Cardiol, 2006, 97(9): 1391-1398.
|
18. |
Elder DH, Wei L, Szwejkowski BR, et al. The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study. J Am Coll Cardiol, 2011, 58(20): 2084-2091.
|
19. |
Sampat U, Varadarajan P, Turk R, et al. Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients. J Am Coll Cardiol, 2009, 54(5): 452-457.
|
20. |
Sawaya FJ, Deutsch MA, Seiffert M, et al. Safety and effificacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results from an International Registry Study. JACC Cardiovasc Interv, 2017, 10(6): 1048-1056.
|
21. |
Jiang J, Liu X, He Y, et al. Transcatheter aortic valve replacement for pure native aortic valve regurgitation: a systematic review. Cardiology, 2018, 141(3): 132-140.
|
22. |
Masri A, Svensson LG, Griffin BP, et al. Contemporary natural history of bicuspid aortic valve disease: a systematic review. Heart, 2017, 103(17): 1323-1330.
|
23. |
Nunes MCP, Tan TC, Elmariah S, et al. Net atrioventricular compliance is an independent predictor of cardiovascular death in mitral stenosis. Heart, 2017, 103(23): 1891-1898.
|
24. |
Bertrand PB, Mihos CG, Yucel E. Mitral annular calcification and calcific mitral stenosis: therapeutic challenges and considerations. Curr Treat Options Cardiovasc Med, 2019, 21(4): 19.
|
25. |
Guerrero M, Urena M, Himbert D, et al. 1-year outcomes of transcatheter mitral valve replacement in patients with severe mitral annular calcification. J Am Coll Cardiol, 2018, 71(17): 1841-1853.
|
26. |
Nanjappa MC, Ananthakrishna R, Hemanna SS, et al. Acute severe mitral regurgitation following balloon mitral valvotomy: echocardiographic features, operative findings, and outcome in 50 surgical cases. Catheter Cardiovasc Interv, 2013, 81(4): 603-608.
|
27. |
Watanabe N. Acute mitral regurgitation. Heart, 2019, 105(9): 671-677.
|
28. |
Pillai AA, Balasubramonian VR, Munuswamy H, et al. Acute severe mitral regurgitation with cardiogenic shock following balloon mitral valvuloplasty: echocardiographic findings and outcomes following surgery. Cardiovasc Interv Ther, 2019, 34(3): 260-268.
|
29. |
David TE, David CM, Tsang W, et al. Long-term results of mitral valve repair for regurgitation due to leaflet prolapse. J Am Coll Cardiol, 2019, 74(8): 1044-1053.
|
30. |
Sorajja P, Vemulapalli S, Feldman T, et al. Outcomes with transcatheter mitral valve repair in the United States: an STS/ACC TVT registry report. J Am Coll Cardiol, 2017, 70(19): 2315-2327.
|
31. |
Michler RE, Smith PK, Parides MK, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med, 2016, 374(20): 1932-1941.
|
32. |
Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med, 2016, 374(4): 344-353.
|
33. |
Grayburn PA, Carabello B, Hung J, et al. Defining “severe” secondary mitral regurgitation: emphasizing an integrated approach. J Am Coll Cardiol, 2014, 64(25): 2792-2801.
|
34. |
Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med, 2018, 379(24): 2307-2318.
|
35. |
Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med, 2018, 379(24): 2297-2306.
|